| Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure (NCT00168116) | AHS Cancer Control Alberta | 2000-07-01 |
| Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer (NCT00544414) | City of Hope Medical Center | 2000-06-07 |
| Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer (NCT00006033) | H. Lee Moffitt Cancer Center and Research Institute | 2000-06-01 |
| Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer (NCT00899821) | NYU Langone Health | 2000-06-01 |
| Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer (NCT00004917) | Radiation Therapy Oncology Group | 2000-06-01 |
| Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00020189) | National Cancer Institute (NCI) | 2000-06-01 |
| SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck (NCT00005647) | Case Comprehensive Cancer Center | 2000-05-01 |
| Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT00611754) | Sanofi | 2000-05-01 |
| Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy (NCT00004226) | University of Alabama at Birmingham | 2000-05-01 |
| Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer (NCT00005088) | Radiation Therapy Oncology Group | 2000-04-01 |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00006036) | NCIC Clinical Trials Group | 2000-03-22 |
| Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer (NCT00005087) | Radiation Therapy Oncology Group | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer (NCT00005035) | Ohio State University Comprehensive Cancer Center | 1999-12-01 |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma (NCT00004261) | University Health Network, Toronto | 1999-12-01 |
| Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer (NCT00005814) | Memorial Sloan Kettering Cancer Center | 1999-12-01 |
| Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy (NCT00004865) | Jonsson Comprehensive Cancer Center | 1999-11-01 |
| S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer (NCT00003908) | SWOG Cancer Research Network | 1999-11-01 |
| Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer (NCT00003206) | Eastern Cooperative Oncology Group | 1999-10-06 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer (NCT00004901) | Robert H. Lurie Cancer Center | 1999-10-01 |
| Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer (NCT00004163) | Dana-Farber Cancer Institute | 1999-10-01 |
| Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer (NCT00021333) | Fox Chase Cancer Center | 1999-09-01 |
| Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer (NCT00003809) | Eastern Cooperative Oncology Group | 1999-08-06 |
| Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx (NCT00004234) | NCIC Clinical Trials Group | 1999-08-02 |
| Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx (NCT00004164) | Dana-Farber Cancer Institute | 1999-08-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer (NCT00004089) | National Cancer Institute (NCI) | 1999-08-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer (NCT00004097) | National Cancer Institute (NCI) | 1999-08-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx (NCT00004094) | National Cancer Institute (NCI) | 1999-08-01 |
| ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer (NCT00006106) | National Cancer Institute (NCI) | 1999-07-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer (NCT00004062) | Lucille P. Markey Cancer Center at University of Kentucky | 1999-07-01 |
| Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer (NCT00004070) | Dana-Farber Cancer Institute | 1999-07-01 |
| Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat (NCT00012168) | NYU Langone Health | 1999-05-01 |
| Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer (NCT00003592) | Eastern Cooperative Oncology Group | 1999-04-22 |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer (NCT00007982) | Herbert Irving Comprehensive Cancer Center | 1999-04-01 |
| Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00003850) | National Cancer Institute (NCI) | 1999-04-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00003888) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-04-01 |
| Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx (NCT00004227) | University of Alabama at Birmingham | 1999-04-01 |
| Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer (NCT00291434) | Institute of Radiotherapy and Oncology, Macedonia | 1999-03-01 |
| Gene Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00009841) | University of Pittsburgh | 1999-03-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer (NCT00006051) | UNICANCER | 1999-02-01 |
| Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer (NCT00003777) | Abramson Cancer Center at Penn Medicine | 1998-12-01 |
| Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery (NCT00003744) | Dana-Farber Cancer Institute | 1998-11-01 |
| Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy (NCT00003610) | Alliance for Clinical Trials in Oncology | 1998-10-01 |
| Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx (NCT00003627) | UNICANCER | 1998-10-01 |
| Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy (NCT00003856) | Quintiles, Inc. | 1998-10-01 |
| Docetaxel in Treating Patients With Solid Tumors (NCT00003565) | Alliance for Clinical Trials in Oncology | 1998-09-01 |
| Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers (NCT00568490) | Stanford University | 1998-09-01 |
| Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx (NCT00003637) | National Cancer Centre, Singapore | 1998-09-01 |
| Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer (NCT00004048) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1998-09-01 |
| Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer (NCT00120211) | International Atomic Energy Agency | 1998-09-01 |
| High-dose ICE With Amifostine (NCT00003657) | Dana-Farber Cancer Institute | 1998-07-01 |
| Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer (NCT00003443) | Memorial Sloan Kettering Cancer Center | 1998-07-01 |
| Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer (NCT00003580) | University of Tennessee | 1998-06-01 |
| L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00003430) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel (NCT00003569) | Roswell Park Cancer Institute | 1998-03-01 |
| Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer (NCT00003139) | Radiation Therapy Oncology Group | 1998-03-01 |
| Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00003193) | Massachusetts General Hospital | 1998-01-01 |
| Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer (NCT00003257) | Aventis Pharmaceuticals | 1998-01-01 |
| SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth (NCT00003223) | SWOG Cancer Research Network | 1997-12-01 |
| Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer (NCT00003251) | University of Illinois at Chicago | 1997-12-01 |
| Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00003328) | Boehringer Ingelheim | 1997-12-01 |
| Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer (NCT00003264) | Fox Chase Cancer Center | 1997-10-01 |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (NCT00019331) | National Cancer Institute (NCI) | 1997-10-01 |
| Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer (NCT00004256) | Royal Marsden NHS Foundation Trust | 1997-10-01 |
| S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx (NCT00003040) | SWOG Cancer Research Network | 1997-09-01 |
| Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer (NCT00003327) | Theradex | 1997-09-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003103) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |
| Fenretinide in Treating Patients With Leukoplakia of the Mouth (NCT00004161) | University of Alabama at Birmingham | 1997-06-01 |
| Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer (NCT00006341) | Jonsson Comprehensive Cancer Center | 1997-06-01 |
| Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck (NCT00002932) | Radiation Therapy Oncology Group | 1997-05-01 |
| Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer (NCT00002888) | Eastern Cooperative Oncology Group | 1997-03-01 |
| Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck (NCT00003182) | Hope Cancer Institute, Inc. | 1997-03-01 |
| Paclitaxel in Treating Patients With Advanced Head and Neck Cancer (NCT00002922) | Eastern Cooperative Oncology Group | 1997-02-21 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00004604) | Duke University | 1997-02-01 |
| Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery (NCT00003576) | National Cancer Centre, Singapore | 1997-01-01 |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function (NCT00002901) | City of Hope Medical Center | 1996-12-01 |
| Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer (NCT00002947) | Yale University | 1996-10-01 |
| Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer (NCT00019201) | National Cancer Institute (NCI) | 1996-08-01 |
| Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx (NCT00002839) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-07-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer (NCT00002951) | University of Chicago | 1996-06-01 |
| Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00003489) | Burzynski Research Institute | 1996-05-06 |
| Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck (NCT00002695) | ECOG-ACRIN Cancer Research Group | 1996-04-30 |
| SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue (NCT00002735) | SWOG Cancer Research Network | 1996-04-01 |
| Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord (NCT00002727) | Radiation Therapy Oncology Group | 1996-04-01 |
| Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer (NCT00019110) | National Cancer Institute (NCI) | 1995-11-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck (NCT00003200) | Dana-Farber Cancer Institute | 1995-10-01 |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery (NCT00002670) | Radiation Therapy Oncology Group | 1995-09-01 |
| Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx (NCT00004246) | M.D. Anderson Cancer Center | 1995-06-07 |
| Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer (NCT00002632) | Eastern Cooperative Oncology Group | 1995-05-30 |
| Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer (NCT00002659) | Matrix Pharmaceutical | 1995-05-01 |
| Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer (NCT00002964) | Roswell Park Cancer Institute | 1995-02-01 |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors (NCT00002608) | Ottawa Regional Cancer Centre | 1994-05-01 |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer (NCT00002654) | Swiss Cancer Institute | 1994-04-01 |
| High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer (NCT00002555) | European Organisation for Research and Treatment of Cancer - EORTC | 1994-02-01 |
| Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer (NCT00002533) | University of Miami | 1993-02-01 |
| Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer (NCT00002507) | Yale University | 1992-11-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer (NCT00002515) | Memorial Sloan Kettering Cancer Center | 1992-10-01 |
| Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer (NCT00002747) | European Institute of Oncology | 1992-09-01 |
| Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx (NCT00002702) | European Institute of Oncology | 1992-09-01 |